EBAC
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
EBAC
Delisted
EBAC was delisted on the 2nd of March, 2023.
50 hedge funds and large institutions have $94M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
50
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.62M | |
| 2 | +$1.51M | |
| 3 | +$1.01M | |
| 4 |
MTCM
Mint Tower Capital Management
Amsterdam,
Netherlands
|
+$1.01M |
| 5 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$962K |
Top Sellers
| 1 | -$3.69M | |
| 2 | -$992K | |
| 3 | -$969K | |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$671K |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
-$112K |